Arkema's Stock Rises 2.14% to €64.40, Breaking Through Technical Resistance
On Monday noon, specialty chemicals company Arkema's stock advances against the trend, as the SBF 120 drops 0.81% and the CAC 40 falls 0.92%. Arkema ranks among the top ten gains in the broader index, in a Parisian market weighed down by Brent crude soaring above $103. The stock is in a technical overbought territory following its rebound.
A Rise Contrary to a Pressured Parisian Market
Arkema gains 2.14% to €64.40 at mid-session, while the SBF 120 retreats by 0.81%. The stock ranks 8th in terms of gains in the broader index of 120 values, following a movement that began in early May. Over the week, the gain reaches 3.87%. Despite the tense sector environment with Brent crossing $103, up 2.24%, amid a diplomatic deadlock between Tehran and Washington around the Strait of Hormuz, this energy surge weighs on the CAC 40 (-0.92%) and represents a cost factor for a specialty chemist exposed to petrochemical raw materials. The first quarter 2026 report, released on May 6, had pushed the stock up by 2.96% despite a 14% decline in EBITDA to 283 million euros. The group had maintained its target of slight EBITDA growth at constant exchange rates for 2026.
Technical Overbought Condition, Resistance Threshold Crossed
Today's movement pushes the price beyond the resistance threshold of €64.20, as identified in technical data. At €64.40, the stock is trading above the upper limit of the Bollinger bands (€63.83), at 114% of the band, characterizing an overbought configuration. The RSI at 59 remains in a neutral zone, without extremes. The price is significantly above its three moving averages: +4.19% vs MM20 (€61.81), +10.10% vs MM50 (€58.49), and +14.92% vs MM200 (€56.04). This alignment indicates a bullish reversal initiated since the beginning of the year's low, although performance remains slightly negative over three months (-0.69%) and over a year (-2.72%). On May 7, analysts appeared divided on the value, with two notes reaching opposite conclusions. The next key date in the financial calendar is the publication of the first half of 2026 results, expected on July 30, 2026.
